<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03807648</url>
  </required_header>
  <id_info>
    <org_study_id>1050984</org_study_id>
    <nct_id>NCT03807648</nct_id>
  </id_info>
  <brief_title>I USE LR in the ED</brief_title>
  <official_title>Intermountain Utah Study Evaluating the Implementation of Lactated Ringers as Standard Resuscitation Fluid Starting in Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intermountain Health Care, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intermountain Health Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the difference in mortality and major adverse kidney events during and after
      treatment in the emergency department with intravenous fluids per standard of care at 30 days
      before and after the system-wide implementation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 20, 2018</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with major Adverse Kidney Events</measure>
    <time_frame>within 30 days or at hospital discharge</time_frame>
    <description>death from any cause, new renal replacement therapy or persistent renal dysfunction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LR IV Fluids administered</measure>
    <time_frame>Through study completion (an average of 1 year)</time_frame>
    <description>Proportion of LR IV fluids following implementation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of hospital admission and readmission</measure>
    <time_frame>Within 30 days of initial ED encounter</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>Through study completion (an average of 1 year)</time_frame>
    <description>Direct costs of ED care and hospitalization</description>
  </secondary_outcome>
  <enrollment type="Actual">200000</enrollment>
  <condition>Kidney Injury</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data Inclusion</intervention_name>
    <description>Patients in this group will be included in the project</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Data to determine study outcomes will be extracted from the EDW and stored in a secure
        database. No actualy contact with patients will take place for this data-only study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (≥18 years) receiving a minimum of 1000ml of intravenous fluids
             starting in the emergency department per standard of care

        Exclusion Criteria:

          -  Patients aged ≤17 years

          -  Previously enrolled patients with &gt;1 ED admission within the 30-day follow-up period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157-7000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 3, 2019</study_first_submitted>
  <study_first_submitted_qc>January 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2019</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

